In 2018 the FDA initiated a recall of the generic blood pressure medication Valsartan after it was discovered that many lots of the drug were contaminated with the cancer-causing substance N-Nitrosodimethylamine (NDMA). NDMA is a byproduct of a chemical reaction that occurs during the manufacturing process of Valsartan when the atmosphere is too acidic.
NDMA in Valsartan has been linked to numerous types of cancer. While some lots of Valsartan were subject to very low levels of contamination, other lots at certain manufacturing facilities were contaminated with extremely high levels of the carcinogen.
Similarly, Zantac (or ranitidine) has been found to be tainted with the same chemical – NDMA. Low levels of exposure may not be harmful, but the FDA has required manufacturers to conduct testing on all ranitidine and nizatidine products. Any lots with elevated levels of NDMA – above 96 nanograms per day or 0.32 parts per million for ranitidine – should not be released to consumers.
If you or a loved one has been diagnosed with the following cancers after using Valsartan for high blood pressure, or Zantac (ranitidine) for heartburn, contact the product liability attorneys at Egerton Law today for a consultation about your legal rights. Our North Carolina attorneys can help you determine whether you have a claim for compensation.
NDMA has been linked to:
Small intestine cancer
Egerton Law represents clients throughout the state of North Carolina including: Guilford County, Forsyth County, Randolph County, Rockingham County, Montgomery County, Greensboro, Winston-Salem, High Point, Asheboro, Kernersville, Burlington, Graham, Mebane, Thomasville, Denton, Eden, Reidsville, Salisbury, Walkertown, Belews Creek, Clemmons, Jamestown, Randleman, Madison, Siler City, Climax and Elon.